Open label, phase 2 safety, efficacy, and pharmacokinetic study of pre-surgical intramuscular and intraductal fulvestrant in women with invasive breast cancer or DCIS undergoing mastectomy or lumpectomy | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

6323023

Reference Type

Journal Article

Title

Open label, phase 2 safety, efficacy, and pharmacokinetic study of pre-surgical intramuscular and intraductal fulvestrant in women with invasive breast cancer or DCIS undergoing mastectomy or lumpectomy

Author(s)

Feldman, S; Gomberawalla, A; Alonso, A; Rea, J; Quay, S; Lawrence, R

Year

2017

Is Peer Reviewed?

Yes

Journal

Cancer Research
ISSN: 0008-5472
EISSN: 1538-7445

Volume

Issue

4_Supplement

Page Numbers

OT3-02-08-OT3-02-08

DOI

10.1158/1538-7445.SABCS16-OT3-02-08

Web of Science Id

WOS:000397999000111

URL

https://aacrjournals.org/cancerres/article/77/4_Supplement/OT3-02-08/623410/Abstract-OT3-02-08-Open-label-phase-2-safety
Exit